Inventor · disambiguated record
Huijuan Song
Also filed as: SONG HUIJUAN
11 granted patents·8 pending applications·141 citations·filing 2014–2025
88Inventor score
Files withNOVARTIS AG17BROGDON JENNIFER1INST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCIENCES & PEKING UNION MEDICAL COLLEGE1
Top patents by PatentIndex Score
19 records- 0197US9777061B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Oct 3, 2017·85 cites·24 claims
- 0294US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 0393US10640569B2Human mesothelin chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2014·Granted May 5, 2020·15 cites·49 claims
- 0492US10577417B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2015·Granted Mar 3, 2020·10 cites·33 claims
- 0585US2025011461A1Human mesothelin chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0683US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 0782US10851166B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Dec 1, 2020·1 cites·22 claims
- 0882US2024294662A1Human mesothelin chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0979US2025353916A1Treatment of cancer using a cd33 chimeric antigen receptorNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1078US2024317850A1Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1172US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1270US2023052970A1Phosphoglycerate kinase 1 (pgk) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1369US12338287B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Jun 24, 2025·0 cites·24 claims
- 1467US11999794B2Human mesothelin chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted Jun 4, 2024·0 cites·21 claims
- 1564US2020339651A1Methods for b cell preconditioning in car therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1662US11981731B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2020·Granted May 14, 2024·0 cites·17 claims
- 1754US11459390B2Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2016·Granted Oct 4, 2022·0 cites·21 claims
- 1853US12458596B2Immunomodulatory hydrogel and preparation method thereofINST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCIENCES & PEKING UNION MEDICAL COLLEGE·Filed 2024·Granted Nov 4, 2025·0 cites·11 claims
- 1951US2018334490A1Methods for b cell preconditioning in car therapyBROGDON JENNIFER·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →